Search research articles
Contact Us
Filters
Showing results (101-110 of 130) with videos related to
Page
of 13
Sort By:
Blood Advances
|
May 12, 2025
The CLUE Post-Surgery VTE Risk Instrument for Abdominal and Pelvic Surgery: Validation of Patient Risk Factor Component
Kari A O Tikkinen, Deborah M Siegal, P J Devereaux, et al.
Thrombosis and Haemostasis
|
January 1, 2019
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations
Raffaele De Caterina, Walter Ageno, Giancarlo Agnelli, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 23, 2022
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
Paul L den Exter, Scott C Woller, Helia Robert-Ebadi, et al.
Critical Care Medicine
|
October 12, 2021
Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis
Alexandre Tran, Shannon M Fernando, Bram Rochwerg, et al.
American Journal of Hematology
|
November 10, 2025
A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study
Tzu-Fei Wang, Erik Yeo, Peter L Gross, et al.
BMJ Open
|
December 12, 2025
Is there a role for anticoagulation with dabigatran in S. aureus bacteremia? Protocol for the adjunctive treatment domain of the <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) randomised controlled trial
Emily G McDonald, Matthew P Cheng, Joshua S Davis, et al.
The New England Journal of Medicine
|
November 13, 2015
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
Deborah M Siegal, John T Curnutte, Stuart J Connolly, et al.
Journal of the American Medical Directors Association
|
September 2, 2024
Oral Anticoagulant Use and Post-Fall Mortality in Long-Term Care Home Residents
Christina Y Yin, Mary M Scott, Maren Kimura, et al.
The Journal of Surgical Research
|
August 26, 2025
Randomized Controlled Trials for the Prevention of Venous Thromboembolism in Trauma and Emergency General Surgery Patients: A Systematic Review of Sample Size Methodologies
Kevin M Durr, Joseph Tropiano, Bram Rochwerg, et al.
Blood Advances
|
March 17, 2026
Perioperative Management of Antithrombotic Therapy in Patients with Thrombotic Antiphospholipid Syndrome
Miguel L Paquette, Sebastien Miranda, Yan Xu, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 130) with videos related to
Sort By:
Page
of 13
Blood Advances
|
May 12, 2025
The CLUE Post-Surgery VTE Risk Instrument for Abdominal and Pelvic Surgery: Validation of Patient Risk Factor Component
Kari A O Tikkinen, Deborah M Siegal, P J Devereaux, et al.
Thrombosis and Haemostasis
|
January 1, 2019
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations
Raffaele De Caterina, Walter Ageno, Giancarlo Agnelli, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 23, 2022
Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
Paul L den Exter, Scott C Woller, Helia Robert-Ebadi, et al.
Critical Care Medicine
|
October 12, 2021
Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis
Alexandre Tran, Shannon M Fernando, Bram Rochwerg, et al.
American Journal of Hematology
|
November 10, 2025
A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study
Tzu-Fei Wang, Erik Yeo, Peter L Gross, et al.
BMJ Open
|
December 12, 2025
Is there a role for anticoagulation with dabigatran in S. aureus bacteremia? Protocol for the adjunctive treatment domain of the <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) randomised controlled trial
Emily G McDonald, Matthew P Cheng, Joshua S Davis, et al.
The New England Journal of Medicine
|
November 13, 2015
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
Deborah M Siegal, John T Curnutte, Stuart J Connolly, et al.
Journal of the American Medical Directors Association
|
September 2, 2024
Oral Anticoagulant Use and Post-Fall Mortality in Long-Term Care Home Residents
Christina Y Yin, Mary M Scott, Maren Kimura, et al.
The Journal of Surgical Research
|
August 26, 2025
Randomized Controlled Trials for the Prevention of Venous Thromboembolism in Trauma and Emergency General Surgery Patients: A Systematic Review of Sample Size Methodologies
Kevin M Durr, Joseph Tropiano, Bram Rochwerg, et al.
Blood Advances
|
March 17, 2026
Perioperative Management of Antithrombotic Therapy in Patients with Thrombotic Antiphospholipid Syndrome
Miguel L Paquette, Sebastien Miranda, Yan Xu, et al.
Page
of 13